These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 15681097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM, Castelnuovo B, Mugasha EB, Ocama P, Kambugu A.
    Clin Infect Dis; 2007 Aug 15; 45(4):514-7. PubMed ID: 17638205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A, Lewi D, Lanzoni V, Wey SB, Odashiro LN, Gomes PS, Silva E.
    Braz J Infect Dis; 2000 Jun 15; 4(3):151-5. PubMed ID: 10934499
    [Abstract] [Full Text] [Related]

  • 12. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
    Noguera A, Fortuny C, Sanchez E, Artuch R, Vilaseca MA, Muñoz-Almagro C, Pou J, Jiménez R.
    Pediatr Infect Dis J; 2003 Sep 15; 22(9):778-82. PubMed ID: 14506367
    [Abstract] [Full Text] [Related]

  • 13. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
    Dragovic G, Jevtovic D.
    Biomed Pharmacother; 2012 Jun 15; 66(4):308-11. PubMed ID: 22658063
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
    Manosuthi W, Prasithsirikul W, Chumpathat N, Suntisuklappon B, Athichathanabadi C, Chimsuntorn S, Sungkanuparph S.
    Int J Infect Dis; 2008 Nov 15; 12(6):582-6. PubMed ID: 18337140
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K, Flepp M, Sudre P, Furrer H, Haensel A, Hirschel B, Boggian K, Chave JP, Bernasconi E, Egger M, Opravil M, Rickenbach M, Francioli P, Telenti A.
    Clin Infect Dis; 2001 Dec 01; 33(11):1931-7. PubMed ID: 11692306
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG, Karstaedt AS.
    Clin Infect Dis; 2007 Jul 15; 45(2):254-60. PubMed ID: 17578788
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.